{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:14:22Z","timestamp":1758935662967},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.leukres.2007.02.015","type":"journal-article","created":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T11:13:42Z","timestamp":1177672422000},"page":"1529-1535","source":"Crossref","is-referenced-by-count":12,"title":["Targeting NF-\u03baB and induction of apoptosis by novel NF-\u03baB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells"],"prefix":"10.1016","volume":"31","author":[{"given":"Noriko","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanoko","family":"Kohmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2007.02.015_bib1","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.02.015_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","article-title":"Burkitt's lymphoma: clinicopathologic features and differential diagnosis","volume":"11","author":"Ferry","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.leukres.2007.02.015_bib3","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","article-title":"Molecular biology of Burkitt's lymphoma","volume":"18","author":"Hecht","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2007.02.015_bib4","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.02.015_bib5","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1073\/pnas.83.9.2984","article-title":"Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma","volume":"83","author":"Pelicci","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.02.015_bib6","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Lymphoma\/leukemia molecular profiling project. Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2007.02.015_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2007.02.015_bib8","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1038\/sj.onc.1203238","article-title":"Control of apoptosis by Rel\/NF-kappaB transcription factors","volume":"18","author":"Barkett","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.02.015_bib9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1182\/blood-2002-07-2009","article-title":"Cell cycle deregulation in B-cell lymphomas","volume":"101","author":"Sanchez-Beato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.02.015_bib10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2007.02.015_bib11","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","article-title":"Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2007.02.015_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/MCB.20.2.556-562.2000","article-title":"The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc","volume":"20","author":"McMahon","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2007.02.015_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1008289430541","article-title":"Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma","volume":"8","author":"Williams","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2007.02.015_bib14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/jnci\/90.15.1146","article-title":"Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model","volume":"90","author":"Smith","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.leukres.2007.02.015_bib15","first-page":"4342","article-title":"Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor","volume":"58","author":"Orlowski","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2007.02.015_bib16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cncr.20182","article-title":"Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies","volume":"100","author":"Panwalkar","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2007.02.015_bib17","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/sj.onc.1203221","article-title":"Aberrant rel\/nfkb genes and activity in human cancer","volume":"18","author":"Rayet","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.02.015_bib18","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1073\/pnas.94.23.12592","article-title":"The Epstein\u2013Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2007.02.015_bib19","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/JVI.77.8.5000-5007.2003","article-title":"Latent membrane protein 1 inhibits Epstein\u2013Barr virus lytic cycle induction and progress via different mechanisms","volume":"77","author":"Prince","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.leukres.2007.02.015_bib20","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1038\/sj.onc.1208969","article-title":"Activation of NF-kappaB by HTLV-I and implications for cell transformation","volume":"24","author":"Sun","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2007.02.015_bib21","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1016\/S0968-0896(02)00315-2","article-title":"Synthesis and structure\u2013activity relationship of dehydroxymethylepoxyquinomicin analogues as inhibitors of NF-kappaB functions","volume":"10","author":"Chaicharoenpong","year":"2002","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.leukres.2007.02.015_bib22","doi-asserted-by":"crossref","first-page":"24625","DOI":"10.1074\/jbc.M112063200","article-title":"Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin","volume":"277","author":"Ariga","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2007.02.015_bib23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1158\/1078-0432.1287.11.3","article-title":"Targeting of nuclear factor kappaB pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo","volume":"11","author":"Matsumoto","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2007.02.015_bib24","first-page":"107","article-title":"Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice","volume":"63","author":"Kikuchi","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2007.02.015_bib25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/1535-7163.MCT-04-0198","article-title":"Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, induces apoptosis in multiple myeloma cells in an IkappaBalpha-independent manner","volume":"4","author":"Tatetsu","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.leukres.2007.02.015_bib26","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/carcin\/bgi095","article-title":"In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia","volume":"26","author":"Ohsugi","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.leukres.2007.02.015_bib27","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-04-0463","article-title":"Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin","volume":"10","author":"Starenki","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2007.02.015_bib28","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1172\/JCI26251","article-title":"Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function","volume":"115","author":"Wright","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2007.02.015_bib29","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","article-title":"A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells","volume":"18","author":"Cuni","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.02.015_bib30","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1182\/blood-2002-06-1768","article-title":"The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications","volume":"101","author":"Mitsiades","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.02.015_bib31","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-03-0494","article-title":"Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors","volume":"10","author":"Zheng","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2007.02.015_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.leu.2403998","article-title":"The NF-kappaB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance","volume":"20","author":"Cilloni","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2007.02.015_bib33","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2003-09-3037","article-title":"Interruption of the NF-kappaB pathway by Bay 11\u20137082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells","volume":"103","author":"Dai","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.02.015_bib34","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","article-title":"Map kinase signaling pathways and hematologic malignancies","volume":"101","author":"Platanias","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2007.02.015_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/35104560","article-title":"Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signaling","volume":"414","author":"De Smaele","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2007.02.015_bib36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncb1093","article-title":"Gadd45 beta mediates the NF-kappa B suppression of JNK signaling by targeting MKK7\/JNKK2","volume":"6","author":"Papa","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.leukres.2007.02.015_bib37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.cdd.4401865","article-title":"The NF-\u03baB-mediated control of the JNK cascade in the antagonism of health and disease","volume":"13","author":"Papa","year":"2006","journal-title":"Cell Death Differentiation"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607000860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212607000860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T16:32:21Z","timestamp":1683822741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212607000860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0145212607000860"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2007.02.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}